Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Analyst Comment

Remedy finds good strategic partner for Control 2

By Atte RiikolaAnalyst
Remedy Entertainment

Translation: Original comment published in Finnish on 8/30/2024 at 7:17 am EEST.

Remedy announced on Thursday a strategic partnership agreement with Annapurna Pictures for Control 2. Remedy will self-publish the game, but Annapurna will fund 50% of the game and have the rights to extend the Control and Alan Wake brands into film and television. In our projections, we had assumed that Remedy would fund Control 2 entirely on its own and raise additional funds to do so. The current agreement is more balanced from a risk perspective and eliminates the need for additional funding that we had anticipated. At the same time, the deal offers good royalty potential and a low-risk opportunity to reach new audiences through movies and TV series. Overall, we view the deal as good for Remedy and will update our forecasts accordingly in the near future.

The deal appears to offer a balanced risk/reward for Remedy

Under the terms of the agreement, Annapurna will fund 50% of the development budget for Control 2 and will have the rights to extend the Control and Alan Wake franchises into film and television. We expect the budget for the game to remain as previously announced (50 MEUR).

Remedy and Annapurna will split the game's revenue equally until the game's production budget is recouped. Remedy will then receive a larger share of game sales, since as the publisher of the game, the company is also responsible for marketing costs (at least 10-30% of the production budget for a typical AAA game). Thus, Remedy's share after recouping the development budget could be estimated at around 60-75% of sales revenues. In return, Annapurna will receive a greater share of audiovisual productions in which Remedy does not have to invest capital.

As part of the agreement, Annapurna will acquire an option to the television and film rights to Control and Alan Wake, as well as selected audiovisual licensing rights and related ancillary products. Remedy retains all intellectual property rights to Control and Alan Wake. As a result, Remedy has complete freedom to decide the fate of a potential Control 3 game project. Annapurna seems to be a quality producer of movies and TV series, so Remedy's game brands seem to be in good hands from that perspective.

Presumably, the signing of the contract will result in a higher volume of development fees for Q3 in proportion to the development done so far on Control 2. Considering this and future development fees, Remedy's cash position (Q2'24: 26.1 MEUR) appears to be sufficient to finance the next projects and to pay the two remaining installments for the Control rights to 505 Games.

Condor will apparently also be self-published

Based on the wording of the press release "self-publishing selected titles", Remedy will also self-publish Condor. We had expected Remedy to co-publish the project with a partner. In light of the Annapurna agreement, we continue to see the possibility that Condor will also bring in a partner in some form to share the financial risk. An interesting option, we think, would be to work with Sony or Microsoft. In this case, Condor could be immediately introduced to the masses on subscription services for these platforms (PlayStation Plus / Game Pass), Remedy would receive some compensation for this and Condor would potentially get a flying start in terms of player numbers.

Remedy Entertainment is a game developer. Its operations are primarily focused on the development of action games, with a particular focus on 3D technology. Examples of games that the company has developed include several different versions of Alan Wake, Max Payne, and Control. Remedy also develops its own game engine and tooling technology that powers many of its games. The company was founded in 1995 and is headquartered in Espoo, Finland.

Read more on company page

Key Estimate Figures2024-08-11

202324e25e
Revenue33.952.852.1
growth-%-22.2 %55.6 %-1.4 %
EBIT (adj.)-28.6-2.6-8.9
EBIT-% (adj.)-84.4 %-5.0 %-17.0 %
EPS (adj.)-1.68-0.14-0.52
Dividend0.000.000.00
Dividend %
P/E (adj.)neg.neg.neg.
EV/EBITDAneg.196.4neg.

Forum discussions

It seems quite clear that both characters are in the game and are related to the story. The open question is whether both are playable. It’s...
9 hours ago
by Jarnis
2
Unsurprisingly, some parts of the Internet are of the opinion that changing the main character is a mistake and the game is now ruined. From...
10 hours ago
by Flouride
5
Let’s make a separate poll to see if it works this way Control Resonant track sales by the end of 2026 Under 0.5M 0.5M - 0.99M 1M - 1.49M 1....
11 hours ago
by Henkka
2
Very much along the same lines. This increasing probability of momentum is further strengthened when examining the trend in the number of Nordnet...
12 hours ago
by Henkka
7
Control: It’s now just over a day since the first trailer for Control: Resonant was released. I took a closer look at the game’s reception, ...
13 hours ago
by Akee
34
Hello to the thread. I’ve also been a long-time Remedy bear, but I took a big position on this last Friday for under 16e. Not investment advice...
13 hours ago
by Umpi
13
Great trailer and the hype started nicely. Hopefully, the Remedyverse is hammered with a customizable sledgehammer into the black hole at the...
yesterday
by T4K1_
5
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.